Pneumocystis jirovecii: One hundred years of history;Pneumocystis jirovecii: Cien años de historia

Revista Cubana de Medicina Tropical

Volumn 63, Issue 2, 2011, Pages

  Sandubete, Enrique Calderón ^a   de Armas Rodríguez, Yaxsier ^b   de Paz, Virginia Capó ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^c IPK   (Cuba)

Author keywords

Biology; Epidemiology; History; Pneumocystis; Review

Indexed keywords

EID: 79959502784     PISSN: 03750760     EISSN: 15613054     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Calderon EJ, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Review Anti-Infective Therapy. 2010;8(6):683-701.
2. Dei-Cas E. Pneumocystis infections: the iceberg? Med Mycol. 2000;38(suppl 1):23-32.
3. Chagas C. Nova tripanozomiazaea humana. Mem Inst Oswaldo Cruz. 1909;1:159-218.
4. Carini A. Formas de eschizogonia do trypanosoma lewisi. Bol Soc Med Cir Sao Paulo. 1910;18:204.
5. Delanöe P, Delanöe M. Sur les rapports des kystes de carinii du poumon des rats avec le Trypanosoma lewisi. CR Acad Sci (Paris) 1912; 155: 658-60.
6. Calderón-Sandubete EJ, Varela-Aguilar JM, Medrano-Ortega FJ, Nieto-Guerrer V, Respaldiza-Salas N, de la Horra-Padilla C. et al. Historical perspective on Pneumocystis carinii infection. Protist. 2002;153(3):303-10.
7. Porter A. The occurrency of Pneumocystis carinii in mice in England. Parasitology. 1915;8:255.
8. Ammich O. Über die nichtsyphilitische interstitielle Pneumonie des ersten Kindesalters. Virchows Arch Pathol Anat. 1938;302:539-54.
9. Benecke E. Eigenartige Bronchiolenerkraskung im ersten Lebensjahr. Verh Dtsch Ges Pathol. 1938;31:402-6.
10. Rubin E, Zak FG. Pneumocystis carinii pneumonia in the adult. N Engl J Med. 1960;262:1315-7.
11. Walzer PD, Perl DP, Krogstead DJ, Rawson P, Schultz MG. Pneumocystis carinii pneumonia in the Unites States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974;80:83-93.
12. Frenkel JK. Pneumocystis jiroveci n.sp. from man: morphology, physiology, and immunology in relation to pathology. Natl Cancer Inst Monogr. 1976;43:13-30.
13. Vavra J, Kucera K. Pneumocystis carinii delanoë, its ultrastructure and ultrastructural affinities. J Protozool. 1970;17(3):463-83.
14. Stringer SL, Stringer JR, Blas MA. Pneumocystis carinii: sequence from ribosome RNA implies a clear relationship with fungi. Exp Parasitol. 1989;68:450-61.
15. Dei-Cas E, Mazars E, Aliouat EM, Nevez G, Cailliez JC, Camus D. The host-specificity of Pneumocystis carinii. J Mycol Med. 1998;8:1-6.
16. Pneumocystis Workshop. Revised nomenclature for Pneumocystis carinii. J Eukaryot Microbiol. 1994;41:121S-2S.
17. Redhead SA, Cushion M, Frenkel JK, Stringer JR. Pneumocystis and Trypanosoma cruzi: Nomenclature and Typifications. J Eukaryot Microbiol. 2006;53(1):2-11.
18. Kovacs JA, Masur H. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA. 2009;301(24):2578-85.
19. Aliouat-Denis CM, Martinez A, Aliouatel M, Pottier M, Gantois N, Dei-Cas E. The Pneumocystis life cycle. Mem Inst Oswaldo Cruz. 2009;104(3):419-26.
20. Matsumoto Y, Yoshida Y. Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J Protozool. 1984;31(3):420-8.
21. Bartlett MS, Verbanac PA, Smith JW. Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol. 1979;10(6):796-9.
22. Cushion MT, Ebbets D. Growth and metabolism of Pneumocystis carinii in axenic culture. J Clin Microbiol. 1990;28(6):1385-94.
23. Mirovsky P, Fishman JA. An improved method for the prolonged maintenance of Pneumocystis carinii in vitro. J Infect Dis. 1993;167(6):1470-3
24. Merali S, Frevert U, Williams JH, Chin K, Bryan R, et al. Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci USA. 1999;96(5):2402-7.
25. Dei-Cas E, Brun-Pascaud M, Bille-Hansen V, Allaert A, Aliouat EM. Animal models of pneumocystosis. FEMS Immunol Med Microbiol. 1998;22(1-2):163-8.
26. Wakefield AE, Stringer JR, Tamburrini E, Dei-Cas E. Genetics, metabolism and host specificity of Pneumocystis carinii. Med Mycol. 1998;36 Suppl 1:183-93.
27. Kaneshiro ES. Lipid metabolism of Pneumocystis: toward the definition of new molecular targets. FEMS Immunol Med Microbiol. 1998;22(1-2):135-43.
28. Nkinin SW, Daly KR, Walzer PD, Ndzi ES, Asonganyi T, et al. Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians. Acta Trop. 2009;112(2):219-24.
29. Kottom TJ, Köhler JR, Thomas CF Jr, Fink GR, Limper AH. Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast. Infect Immun. 2003;71(11):6463-7.
30. Ambrose HE, Keely SP, Aliouat EM, Dei-Cas E, Wakefield AE, et al. Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology. 2004;150(Pt 2):293-300.
31. Cushion MT, Smulian AG, Slaven BE, Sesterhenn T, Arnold J, Staben C, Porollo A, Adamczak R, Meller J. Transcriptome of Pneumocystis carinii during fulminate infection: carbohydrate metabolism and the concept of a compatible parasite. PLoS One. 2007;2(5):423.
32. Wakefield AE. Genetic heterogeneity in Pneumocystis carinii: an introduction. FEMS Immunol Med Mic. 1998;22:5-13.
33. Wakefield AE. Pneumocystis carinii. Br Med Bull. 2002;61:175-88.
34. Stringer JR, Cushion MT. The genome of Pneumocystis carinii. FEMS Immunol Med Microbiol. 1998;22:15-26.
35. Helweg-Larsen J. Pneumocystis jiroveci. Applied molecular microbiology, epidemiology and diagnosis. Dan Med Bull. 2004;51(3):251-73.
36. Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10(10):1713-20.
37. Russian DA, Levine SJ. Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci. 2001;321(1):56-65.
38. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34(8):1098-107.
39. Cisneros JM, Muñoz P, Torre-Cisneros J, Gurgui M, Rodriguez-Hernandez MJ, et al. Pneumonia after heart transplantation: a multiinstitutional study. Clin Infect Dis. 1998;27:324-31.
40. Calderón EJ, Varela JM, Medrano FJ, Nieto V, González-Becerra C, et al. Epidemiology of Pneumocystis carinii pneumonia in southern Spain. Clin Microbiol Infect. 2004;10(7):673-6.
41. Respaldiza N, Medrano FJ, Medrano AC, Varela JM, de la Horra C, et al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect. 2004;10(11):1029-31.
42. Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32(6):855-61.
43. Cano S, Capote F, Pereira A, Calderón E, Castillo J. Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest.1993;104:376-81.
44. Jacobs JL, Libby DM, Winters RA, Gelmont DM, Fried ED, et al. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med. 1991;324:246-50.
45. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis. 2008;197:10-7.
46. Wissmann G, Morilla R, Friaza V, Calderón E, Varela JM. Human reservoirs of Pneumocystis. Enferm Infecc Microbiol Clin. 2010;28(1):38-43.
47. Calderón EJ, Friaza V, Dapena FJ, de la Horra C. Pneumocystis jirovecii and cystic fibrosis. Med Mycol. 2010;48(O1):S17-S21.
48. Bartlett MS, Lee CH. Airborne spread of Pneumocystis jirovecii. Clin Infect Dis. 2010;50(3):266.
49. Ponce CA, Gallo M, Bustamante R, Vargas SL. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis. 2010;50(3):347-53.
50. Wissmann G, Varela JM, Calderón EJ. Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization. Inflamm Bowel Dis. 2008;14(12):1751-2.
51. Nevez G, Chabé M, Rabodonirina M, Virmaux M, Dei-Cas E, et al. Nosocomial Pneumocystis jirovecii infections. Parasite. 2008;15(3):359-65.
52. Keely SP, Stringer JR. Multi-locus genotype switching in Pneumocystis carinii sp. f. hominis: evidence for reinfection. J Eukaryot Microbiol. 1996;43(5):50S.
53. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6(3):265-72.
54. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis. 2000;182(4):1192-8.
55. de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis. 2007;44(9):1143-9.
56. Hauser PM, Nahimana A, Taffe P, Weber R, Francioli P, Bille J, et al. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis. 2010;51(4):e28-33.
57. Vargas SL, Hughes WT, Wakefield AE, Oz HS. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis. 1995;172(2):506-10.
58. Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev. 1997;10(3):401-18.
59. Manoloff ES, Francioli P, Taffé P, Van Melle G, Bille J, Hauser PM. Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study. Emerg Infect Dis. 2003;9(1):132-4.
60. Boylan CJ, Current WL. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infect Immun. 1992;60(4):1589-97.
61. Dumoulin A, Mazars E, Seguy N, Gargallo-Viola D, Vargas S, et al. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis. 2000;19(9):671-8.
62. Rivero L, de la Horra C, Montes-Cano MA, Rodríguez-Herrera A, Respaldiza N, et al. Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis. 2008;14(7):1116-8.
63. Olsson M, Strålin K, Holmberg H. Clinical significance of nested polymerase chain reaction and immunofluorescence for detection of Pneumocystis carinii pneumonia. Clin Microbiol Infect. 2001;7(9):492-7.
64. Montes-Cano MA, Chabe M, Fontillon-Alberdi M, de-Lahorra C, Respaldiza N, et al. Vertical transmission of Pneumocystis jirovecii in humans. Emerg Infect Dis. 2009;15(1):125-7.
65. Mortier E, Pouchot J, Bossi P, Molinie V. Maternal-fetal transmission of Pneumocystis carinii in human immunodeficiency virus infection. N Engl J Med. 1995;332:825
66. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487-98.
67. Huang L, Morris A, Limper AH, Beck JM. ATS Pneumocystis Workshop Participants. An Official ATS Workshop Summary: Recent advances and future directions in Pneumocystis neumonia (PCP). Proc Am Thorac Soc. 2006;3(8):655-64.
68. Huang L. Clinical presentation and diagnosis of Pneumocystis pneumonia in HIV- infected patients. In: Walzer P, editor. Pneumocystis pneumonia. 3a ed. Marcel and Dekker; 2005. p. 349-406.
69. Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17(4):770-82.
70. Phair J, Muñoz A, Detels R, Kaslow R, Rinaldo C, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990;322(3):161-5.
71. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100(5):663-71.
72. Opravil M, Marincek B, Fuchs WA, Weber R, Speich R, et al. Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr. 1994;7(1):39-45.
73. Jasmer RM, Edinburgh KJ, Thompson A, Gotway MB, Creasman JM, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV- infected patients. Chest. 2000;117(4):1023-30.
74. Baughman RP, Liming JD. Diagnostic strategies in Pneumocystis carinii pneumonia. Front Biosci. 1998;3:1-12.
75. Sandhu JS, Goodman PC. Pulmonary cysts associated with Pneumocystis carinii pneumonia in patients with AIDS. Radiology. 1989;173:33-5.
76. Varthalitis I, Aoun M, Daneau D, Meunier F. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 1993; 71: 481-485.
77. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest. 2007;131(4):1173-80.
78. Boldt MJ, Bai TR. Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest. 1997;111(5):1187-92.
79. Fernandez P, Torres A, Miro JM, Vieigas C, Mallolas J, et al. Prognostic factors influencing the outcome in Pneumocystis carinii pneumonia in patients with AIDS. Thorax. 1995;50(6):668-71.
80. Skelly M, Hoffman J, Fabbri M, Holzman RS, Clarkson AB Jr, et al. S- adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet. 2003;361(9365):1267-8.
81. Höcker B, Wendt C, Nahimana A, Tönshoff B, Hauser PM. Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis. 2005;11(2):330-2.
82. Nakamura H, Tateyama M, Tasato D, Haranaga S, Yara S, et al. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med. 2009;48(4):195-202.
83. Tasaka S, Kobayashi S, Kamata H, Kimizuka Y, Fujiwara H, et al. Cytokine profiles of bronchoalveolar lavage fluid in patients with Pneumocystis pneumonia. Microbiol Immunol. 2010;54(7):425-33.
84. Shimizu Y, Sunaga N, Dobashi K, Fueki M, Fueki N, et al. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis. 2009;9:47.
85. Sage EK, Noursadeghi M, Evans HE, Parker SJ, Copas AJ, et al. Prognostic value of C- reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS. 2010;21(4):288-92.
86. Durand-Joly I, Chabé M, Soula F, Delhaes L, Camus D, et al. E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol. 2005;45(3):405-10.
87. Bava AJ, Cattaneo S, Bellegarde E. Diagnosis of pulmonary pneumocystosis by microscopy on wet mount preparations. Rev Inst Med Trop Sao Paulo. 2002;44(5):279-82.
88. Sun T, Chess Q, Tanenbaum B. Morphologic criteria for the identification of Pneumocystis carinii in Papanicolaou-stained preparations. Acta Cytol. 1986;30(1):80-2.
89. Monheit JG, Brown G, Kott MM, Schmidt WA, Moore DG. Calcofluor white detection of fungi in cytopathology. Am J Clin Pathol. 1986;85(2):222-5.
90. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, et al. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol. 2004;42(7):3333-5.
91. Cregan P, Yamamoto A, Lum A, VanDerHeide T, MacDonald M, et al. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol. 1990;28(11):2432-6.
92. Halford JA, Shield PW, Wright RG. The value of direct fluorescent antibody (DFA) testing for the detection of Pneumocystis carinii in cytological specimens. Cytopathology. 1994;5(4):234-42.
93. Silletti RP, Glezerov V, Schwartz IS. Pulmonary paracoccidioidomycosis misdiagnosed as Pneumocystis pneumonia in an immunocompromised host. J Clin Microbiol. 1996;34(9):2328-30.
94. Armbruster C, Pokieser L, Hassl A. Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol. 1995;39(6):1089-93.
95. Robberts FJ, Liebowitz LD, Chalkley LJ. Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays. Diagn Microbiol Infect Dis. 2007;58(4):385-92.
96. Arcenas RC, Uhl JR, Buckwalter SP, Limper AH, Crino D, et al. A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diag Microbiol Infect Dis. 2006;54(3): 69-75.
97. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet. 1990;336(8713):451-3.
98. Ripamonti C, Orenstein A, Kutty G, Huang L, Schuhegger R, Sing A, et al. Restriction Fragment Length Polymorphism Typing Demonstrates Substantial Diversity among Pneumocystis jirovecii Isolates. J Infect Dis. 2009;200(10):1616-22.
99. Lu JJ, Chen CH, Bartlett MS, Smith JW, Lee CH. Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol. 1995;33(10):2785-8.
100. Helweg-Larsen J, Jensen JS, Lundgren B. Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes. Lancet. 1997 Nov 8;350(9088):1363.
101. Miller RF, Wakefield AE. Pneumocystis carinii genotypes and severity of pneumonia. Lancet. 1999;353(9169):2039-40.
102. Totet A, Duwat H, Magois E, Jounieaux V, Roux P, Raccurt C, et al. Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology. 2004;150(Pt 5):1173-8.
103. Esteves F, Gaspar J, Marques T, Leite R, Antunes F, Mansinho K, et al. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin Microbiol Infect. 2010;16:878-84.
104. Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis. 1997;175(2):482-5.
105. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol. 2004;53(Pt 7):603-7.
106. de Oliveira A, Unnasch TR, Crothers K, Eiser S, Zucchi P, et al. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients. Diagn Microbiol Infect Dis. 2007;57(2):169-76.